By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

The Company Is on Track to Complete the Interim Data Analysis Before the End of Q1 2025 and to Submit the Findings to the U.S. Food and Drug Administration (FDA) Philadelphia, Pennsylvania--(Newsfile ...

Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a ...

Eco Wave Power has entered an MoU with Bharat Petroleum (BPCL) to harness India's wave energy potential, estimated at ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

Karen A. Foster, the Chief Quality and Operations Officer at Biolife Solutions Inc. (NASDAQ:BLFS), recently sold a portion of her company stock. According to a Form 4 filing with the Securities and ...

Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc. (NASDAQ:BLFS), has sold 102 shares of the company's common stock. The transaction was executed on February 12, 2025, at a price of ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

New research has uncovered a complex interplay between extracellular matrix (ECM) structure and the transcriptional responses ...